A Phase II Study to Treat Advanced Malignant Glioma
Condition(s):Advanced Malignant GliomaLast Updated:April 27, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Advanced Malignant GliomaLast Updated:April 27, 2015Completed
Condition(s):High Grade Glioma; Diffuse Intrinsic Pontine GliomaLast Updated:January 30, 2023Active, not recruiting
Condition(s):Malignant GliomaLast Updated:December 16, 2013Terminated
Condition(s):Pilomyxoid Astrocytoma; Pilocytic Astrocytoma; Glioma, Astrocytic; Optic Nerve Glioma; Pleomorphic Xanthoastrocytoma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Gliosarcoma; Diffuse Intrinsic Pontine Glioma; DIPG; Low-grade Glioma; Brainstem GliomaLast Updated:April 13, 2023Recruiting
Condition(s):GliomaLast Updated:March 22, 2024Active, not recruiting
Condition(s):Supratentorial GlioblastomaLast Updated:August 7, 2019Unknown status
Condition(s):High Grade GliomaLast Updated:December 26, 2023Recruiting
Condition(s):Malignant GliomaLast Updated:September 29, 2022Completed
Condition(s):GliomaLast Updated:February 6, 2024Recruiting
Condition(s):Epilepsy; GliomaLast Updated:June 9, 2008Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.